EUVIMEDEUVIMED entdecken
Open Access · CC0

COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January – June 2022

Caleb L Ward iD, Madelyn Yiseth Rojas Castro iD, Giorgi Chakhunashvili iD, Nazibrola Chitadze, Iris Finci, Richard Pebody, Esther Kissling, Mark A Katz, Lia Sanodze

PLOS One · 2025

DOI: 10.1371/journal.pone.0311337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Caleb L Ward und 8 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Institute, Tbilisi, Georgia. Hauptthemen laut MEDLINE: Health Personnel, COVID-19, COVID-19 Vaccines, Vaccine Efficacy. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: World Health Organization, Task Force for Global Health, Centers for Disease Control and Prevention / Public Health Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Understanding COVID-19 vaccine effectiveness (VE) in healthcare workers (HCWs) is critical to inform vaccination policies. We measured COVID-19 VE against laboratory-confirmed symptomatic infection in HCWs in the country of Georgia from January – June 2022, during a period of Omicron circulation.

Methods

We conducted a cohort study of HCWs in six hospitals in Georgia. HCWs were enrolled in early 2021. Participants completed weekly symptom questionnaires. Symptomatic HCWs were tested by RT-PCR and/or rapid antigen test (RAT). Participants were also routinely tested, at varying frequencies during the study period, for SARS-CoV-2 by RT-PCR or RAT, regardless of symptoms. Serology was collected quarterly throughout the study and tested by electrochemiluminescence immunoassay for SARS-CoV-2 antibodies. We estimated absolute and relative VE of a first booster dose compared to a primary vaccine series as (1-hazard ratio)*100 using Cox proportional hazards models.

Results

Among 1253 HCWs, 141 (11%) received a primary vaccine series (PVS) and a first booster, 855 (68%) received PVS only, and 248 (20%) were unvaccinated. Most boosters were BNT162b2 (Comirnaty original monovalent) vaccine (90%) and BBIBP-CorV vaccine (Sinopharm) (9%). Most PVS were BNT162b2 vaccine (68%) and BBIBP-CorV vaccine (24%). Absolute VE for a first booster was 40% (95% Confidence Interval (CI) -56–77) at 7–29 days following vaccination, -9% (95% CI -104–42) at 30–59 days following vaccination, and -46% (95% CI -156–17) at ≥ 60 days following vaccination. Relative VE of first booster dose compared to PVS was 58% (95% CI 1–82) at 7–29 days following vaccination, 21% (95% CI -33–54) at 30–59 days following vaccination, and -9% (95% CI -82–34) at ≥ 60 days following vaccination.

Conclusion

In Georgia, first booster dose VE against symptomatic SARS-CoV-2 infection among HCWs was moderately effective but waned very quickly during Omicron. Increased efforts to vaccinate priority groups in Georgia, such as healthcare workers, prior to periods of anticipated high COVID-19 incidence are essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Health PersonnelCOVID-19COVID-19 VaccinesVaccine EfficacyHumansMaleFemaleGeorgia (Republic)AdultMiddle AgedSARS-CoV-2VaccinationCohort StudiesAntibodies, ViralImmunization, Secondary

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Public Health Institute, Tbilisi, Georgia.
  • Epiconcept, Paris, France.
  • National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • World Health Organization Regional Office for Europe, Copenhagen, Denmark.

ORCID-Profile: Caleb L Ward, Madelyn Yiseth Rojas Castro, Giorgi Chakhunashvili

Förderung

  • World Health Organization
  • Task Force for Global Health
  • Centers for Disease Control and Prevention / Public Health Institute

Zitieren

APA

Ward, C. L., Rojas Castro, M. Y., Chakhunashvili, G., Chitadze, N., Finci, I., Pebody, R., Kissling, E., Katz, M. A., & Sanodze, L. (2025). COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January – June 2022. PLOS One. https://doi.org/10.1371/journal.pone.0311337

Vancouver

Ward CL, Rojas Castro MY, Chakhunashvili G, Chitadze N, Finci I, Pebody R, et al. COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January – June 2022. PLOS One. 2025. doi:10.1371/journal.pone.0311337

BibTeX
@article{Ward2025,
  author = {Ward, Caleb L and Rojas Castro, Madelyn Yiseth and Chakhunashvili, Giorgi and Chitadze, Nazibrola and Finci, Iris and Pebody, Richard and Kissling, Esther and Katz, Mark A and Sanodze, Lia},
  title = {COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January – June 2022},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0311337}
}
Kostenlos starten →